FILINGS
| TBPH 0001583107 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2016-08-25 | 4 | FORM 4 - | View Document |
| 2016-08-23 | 4 | FORM 4 - | View Document |
| 2016-08-23 | 4 | FORM 4 - | View Document |
| 2016-08-23 | 4 | FORM 4 - | View Document |
| 2016-08-23 | 4 | FORM 4 - | View Document |
| 2016-08-23 | 4 | FORM 4 - | View Document |
| 2016-08-23 | 4 | FORM 4 - | View Document |
| 2016-08-22 | 4 | FORM 4 - | View Document |
| 2016-08-09 | 10-Q | 10-Q | View Document |
| 2016-08-08 | 8-K | THERAVANCE BIOPHARMA 8-K | View Document |
| 2016-08-04 | SC 13G/A | AMENDMENT NO. 2 SCHEDULE 13G | View Document |
| 2016-06-14 | 8-K | 8-K | View Document |
| 2016-06-14 | 8-K | 8-K | View Document |
| 2016-05-24 | 4 | FORM 4 - | View Document |
| 2016-05-24 | 4 | FORM 4 - | View Document |
| 2016-05-24 | 4 | FORM 4 - | View Document |
| 2016-05-24 | 4 | FORM 4 - | View Document |
| 2016-05-24 | 4 | FORM 4 - | View Document |
| 2016-05-24 | 4 | FORM 4 - | View Document |
| 2016-05-24 | 4 | FORM 4 - | View Document |
| 2016-05-13 | SC 13D/A | View Document | |
| 2016-05-10 | 10-Q | 10-Q | View Document |
| 2016-05-09 | 8-K | THERAVANCE BIOPHARMA, INC. 8-K | View Document |
| 2016-05-06 | 8-K | 8-K | View Document |
| 2016-05-05 | 4 | FORM 4 - | View Document |
| 2016-05-05 | 4 | FORM 4 - | View Document |
| 2016-05-05 | 4 | FORM 4 - | View Document |
| 2016-05-05 | 4 | FORM 4 - | View Document |
| 2016-05-05 | 4 | FORM 4 - | View Document |
| 2016-05-05 | 4 | FORM 4 - | View Document |
| 2016-05-05 | 4 | FORM 4 - | View Document |
| 2016-05-05 | 4 | FORM 4 - | View Document |
| 2016-05-05 | 4 | FORM 4 - | View Document |
| 2016-05-05 | 4 | FORM 4 - | View Document |
| 2016-05-04 | 8-K | THERAVANCE BIOPHARMA, INC. 8-K | View Document |
| 2016-05-02 | 8-K | 8-K | View Document |
| 2016-04-29 | 424B5 | 424B5 | View Document |
| 2016-04-29 | FWP | FWP | View Document |
| 2016-04-27 | 424B5 | 424B5 | View Document |
| 2016-03-25 | DEF 14A | DEF 14A | View Document |
| 2016-03-24 | SC 13D | View Document | |
| 2016-03-17 | 4 | FORM 4 - | View Document |
| 2016-03-17 | 4 | FORM 4 - | View Document |
| 2016-03-17 | 4 | FORM 4 - | View Document |
| 2016-03-17 | 4 | FORM 4 - | View Document |
| 2016-03-17 | 4 | FORM 4 - | View Document |
| 2016-03-17 | 4 | FORM 4 - | View Document |
| 2016-03-17 | 4 | FORM 4 - | View Document |
| 2016-03-17 | 4 | FORM 4 - | View Document |
| 2016-03-17 | 4 | FORM 4 - | View Document |
| 2016-03-17 | 4 | FORM 4 - | View Document |
| 2016-03-15 | S-8 | S-8 | View Document |
| 2016-03-15 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2016-03-14 | 8-K | 8-K | View Document |
| 2016-03-11 | 10-K | 10-K | View Document |
| 2016-03-09 | 3 | FORM 3 - | View Document |
| 2016-03-09 | 3 | FORM 3 - | View Document |
| 2016-03-09 | 3 | FORM 3 - | View Document |
| 2016-03-09 | 8-K | THERAVANCE BIOPHARMA, INC. 8-K | View Document |
| 2016-03-09 | 8-K | 8-K | View Document |
| 2016-02-25 | 8-K | 8-K | View Document |
| 2016-02-23 | 4 | FORM 4 - | View Document |
| 2016-02-23 | 4 | FORM 4 - | View Document |
| 2016-02-23 | 4 | FORM 4 - | View Document |
| 2016-02-23 | 4 | FORM 4 - | View Document |
| 2016-02-23 | 4 | FORM 4 - | View Document |
| 2016-02-23 | 4 | FORM 4 - | View Document |
| 2016-02-23 | 4 | FORM 4 - | View Document |
| 2016-02-19 | SC 13G/A | AMENDED SCHEDULE 13G | View Document |
| 2016-02-19 | SC 13G/A | AMENDED SCHEDULE 13G | View Document |
| 2016-02-12 | SC 13G/A | NONE | View Document |
| 2016-02-09 | SC 13G/A | View Document | |
| 2016-01-27 | SC 13G/A | View Document | |
| 2016-01-11 | 8-K | 8-K | View Document |
| 2015-11-24 | 4 | FORM 4 - | View Document |
| 2015-11-24 | 4 | FORM 4 - | View Document |
| 2015-11-24 | 4 | FORM 4 - | View Document |
| 2015-11-24 | 4 | FORM 4 - | View Document |
| 2015-11-12 | 10-Q | 10-Q | View Document |
| 2015-11-10 | 8-A12B | 8-A12B | View Document |
| 2015-11-10 | 8-K | 8-K | View Document |
| 2015-11-10 | SC 13G | SCHEDULE 13G | View Document |
| 2015-11-10 | SC 13G | SCHEDULE 13G | View Document |
| 2015-11-09 | 8-K | THERAVANCE BIOPHARMA, INC. 8-K | View Document |
| 2015-10-26 | 424B5 | 424B5 | View Document |
| 2015-10-26 | 8-K | 8-K | View Document |
| 2015-10-23 | 4 | FORM 4 - | View Document |
| 2015-10-23 | 3 | FORM 3 - | View Document |
| 2015-10-13 | 8-K/A | 8-K/A | View Document |
| 2015-10-07 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2015-09-30 | SC TO-I/A | SC TO-I/A | View Document |
| 2015-09-23 | SC TO-I/A | SC TO-I/A | View Document |
| 2015-09-11 | SC TO-I/A | SC TO-I/A | View Document |
| 2015-09-11 | 8-K | 8-K | View Document |
| 2015-09-09 | 8-K | 8-K | View Document |
| 2015-09-02 | SC 13G | View Document | |
| 2015-08-28 | SC TO-I | SC TO-I | View Document |
| 2015-08-28 | 8-K/A | 8-K/A | View Document |
| 2015-08-24 | 4 | FORM 4 - | View Document |
| 2015-08-24 | 4 | FORM 4 - | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
